🇺🇸 FDA
Patent

US 7750121

Antibody to telomerase reverse transcriptive

granted A61KA61K38/00A61K39/00

Quick answer

US patent 7750121 (Antibody to telomerase reverse transcriptive) held by The Regents of the University of Colorado expires Mon Jul 01 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of Colorado
Grant date
Tue Jul 06 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 01 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K38/00, A61K39/00, A61K48/00, A61P